Practitioner Question of the Month – December 2019

Andrea Luchi asks,

“You forget that many of the studies showing no benefits from T4 plus T3 therapy use a vert low dose of T3 ….(14:1 T4: T3 ratio). Look at the studies with a T4:T3 ratio around 4 to 1 and you see benefits in every single study. It is so Simple.”

This is worth double checking.  My current take, it appears the benefit of combination therapy (in the majority of cases) is driven by the placebo effect.  However, we are re-analyzing the data here and will report back on our findings.

If you have found this information helpful please share with a friend using this link: https://drruscio.com/review/

I’d like to hear your thoughts or questions regarding any of the above information. Please leave comments or questions below – it might become our next practitioner question of the month.